Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK launches major bladder radiotherapy trial

This article was originally published in Clinica

Executive Summary

The UK is to host what is being billed as one of the most significant bladder cancer trials of recent years. The project, announced by the charity Cancer Research UK, will aim to assess the value of combining radiotherapy with chemotherapy, as well as comparing two methods of delivering radiotherapy. For the first time, the trial will compare different radiotherapy planning techniques in bladder cancer, dealing with issues such as tumour localisation and reduced-volume radiotherapy.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT066270

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel